We hypothesized that the putamen DAT concentration would distinguish the LB groups from HCS, and that, relative to putamen DAT, the caudate and extrastriatal DAT concentrations would fall in DLB subjects compared with the PD and HCS groups. The gene discussed is SLC6A3; the disease is Parkinson disease.